[EN] BETA-CARBOLINE SULPHONYLUREA DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE BÊTA-CARBOLINE SULFONYLURÉE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR D'EP4
申请人:MERCK FROSST CANADA LTD
公开号:WO2010034110A1
公开(公告)日:2010-04-01
The invention is directed to ß-carboline sulphonylurea derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, inflammation, osteoarthritis, and rheumatoid arthritis. Pharmaceutical compositions and methods of use are also included.
该发明涉及ß-咔啉磺酰脲衍生物作为EP4受体拮抗剂,用于治疗EP4介导的疾病或症状,如急性和慢性疼痛、炎症、骨关节炎和类风湿性关节炎。药物组合物和使用方法也包括在内。